Gold Standard	PhenID	Phen Description
Acetone	phv00031628.v1 	 How certain (0=Very uncertain; 5=moderately certain; 10=very certain) are you that you will be able to carry out  the following: test for acetone at least once/day 
 ABO BLOOD TYPE 	phv00116366.v2 	 ABO BLOOD TYPE 
partial thromboplastin time	phv00109264.v1 	 DOES PTT USE AN ASSISTIVE DEVICE 
partial thromboplastin time	phv00104712.v1 	 DOES PTT USE A RIGHT ARM PROTHESIS 
partial thromboplastin time	phv00105809.v1 	 DOES PTT USE A PROTHESIS 
partial thromboplastin time	phv00115941.v2 	 WHAT PTT WAS DOING WHEN INJURED -CODE3 
partial thromboplastin time	phv00115939.v2 	 WHAT PTT WAS DOING WHEN INJURED -CODE1 
partial thromboplastin time	phv00105804.v1 	 IS PTT MISSING A LIMB 
partial thromboplastin time	phv00110288.v1 	 DOES PTT USE A RIGHT ARM PROTHESIS 
partial thromboplastin time	phv00101693.v1 	 DOES PTT USE AN ASSISTIVE DEVICE 
partial thromboplastin time	phv00110289.v1 	 DOES PTT USE A LEFT LEG PROTHESIS 
partial thromboplastin time	phv00109271.v1 	 IS PTT MISSING LEFT LEG 
partial thromboplastin time	phv00104711.v1 	 DOES PTT USE A LEFT ARM PROTHESIS 
partial thromboplastin time	phv00115942.v2 	 WHAT PTT WAS DOING WHEN INJURED -CODE4 
partial thromboplastin time	phv00107482.v1 	 DOES PTT USE A LEFT LEG PROTHESIS 
partial thromboplastin time	phv00113508.v2 	 HOW OFTEN PTT FEELS THAT OTHERS CARE? Q 8 
partial thromboplastin time	phv00105799.v1 	 CAN PTT DO A TANDEM STAND 
Adiponectin	phv00124099.v1 	 Adiponectin am (pg/mL) 
 albumin excretion rate measurement 	phv00027119.v1 	 Log of AER 
 albumin/globulin ratio 	phv00081028.v1 	 Albumin/Globulin Ratio 
blood glucose measurement 	phv00009578.v3 	 BLOOD ANALYSIS - GLUCOSE - 2 HOUR POST 
SERUM VLDL	phv00001404.v1 	 BLOOD ANALYSIS, FASTING: VLDL BETA BAND 
SERUM CHOLESTEROL	phv00001401.v1 	 BLOOD ANALYSIS, FASTING: BETA CHOLESTEROL (MG/100 ML) 
Hematocrit	phv00002414.v1 	 BLOOD ANALYSIS, HEMATOCRIT 
Serum phospholipid	phv00001383.v1 	 BLOOD ANALYSIS: SERUM PHOSPHOLIPID (MG/100 ML) 
SERUM CHOLESTEROL	phv00113708.v2 	 CHOLESTEROL ANALYSIS DATE 
serum lipids, fasting	phv00007989.v3 	 BLOOD ANALYSIS-FASTING LIPIDS: SINKING PRE-BETA BAND 
serum lipids, fasting; serum cholesterol	phv00001587.v1 	 BLOOD ANALYSIS: FASTING LIPIDS, CHOLESTEROL - BOTTOM FRACTION (ALPHA + BETA) (SEE VARIABLE #47 FOR DECK 141 CHOLESTEROL VALUES RECORDED IN SERUM OR PLASMA UNITS.) 
serum lipids, fasting	phv00007979.v3 	 BLOOD ANALYSIS-FASTING LIPIDS ORIGIN TOP FRACTION (1.006) 
serum cholesterol	phv00001381.v1 	 BLOOD ANALYSIS: BETA CHOLESTEROL (MG/100 ML) 
RNA LEVELS; APOA1; Run4; Platelet	phv00142303.v2 	 RNA LEVELS: APOA1, Run4, Platelet (TaqmanAssayID : Hs00163641_m1) 
RNA LEVELS; CDKN2BAS; L, Run4; Leukocyte	phv00142225.v2 	 RNA LEVELS: CDKN2BAS, L, Run4, Leukocyte(AssaySequences:[forward primer: ACACAGTGCTCAAATCCATGATCT;reverse primer: CAAATTCCTGCCACTTCCTCTACT; probe: CATAGGTGGAGAACTTC]) 
blood glucose measurement 	phv00032680.v1 	 Pre-lunch blood glucose at OD 340 (close-out) 
blood glucose measurement 	phv00032676.v1 	 Pre-breakfast blood glucose at OD 340 (close-out) 
blood glucose measurement 	phv00032899.v1 	 Post-breakfast blood glucose at OD 340 (quarterly visit 11) 
blood glucose measurement 	phv00033295.v1 	 Post-breakfast blood glucose at OD 340 (quarterly visit 29) 
blood glucose measurement 	phv00032771.v1 	 Post-lunch blood glucose at OD 340 (quarterly visit 05) 
blood glucose measurement 	phv00032641.v1 	 Pre-supper blood glucose at OD 340 (quarterly visit 00) 
blood glucose measurement 	phv00033033.v1 	 Pre-lunch blood glucose at OD 340 (quarterly visit 17) 
blood glucose measurement 	phv00033297.v1 	 Pre-lunch blood glucose at OD 340 (quarterly visit 29) 
blood glucose measurement 	phv00033259.v1 	 Post-supper blood glucose at OD 340 (quarterly visit 27) 
blood glucose measurement 	phv00032707.v1 	 Pre-supper blood glucose at OD 340 (quarterly visit 02) 
blood glucose measurement 	phv00033329.v1 	 3:00 a.m. blood glucose at OD 340 (quarterly visit 30) 
blood glucose measurement 	phv00032721.v1 	 Pre-breakfast blood glucose at OD 340 (quarterly visit 03) 
blood glucose measurement 	phv00033411.v1 	 Pre-supper blood glucose at OD 340 (quarterly visit 34) 
blood glucose measurement 	phv00033175.v1 	 3:00 a.m. blood glucose at OD 340 (quarterly visit 23) 
blood glucose measurement 	phv00032831.v1 	 Pre-breakfast blood glucose at OD 340 (quarterly visit 08) 
blood glucose measurement 	phv00032993.v1 	 Pre-supper blood glucose at OD 340 (quarterly visit 15) 
blood glucose measurement 	phv00032845.v1 	 3:00 a.m. blood glucose at OD 340 (quarterly visit 08) 
blood glucose measurement 	phv00032705.v1 	 Post-lunch blood glucose at OD 340 (quarterly visit 02) 
blood glucose measurement 	phv00032779.v1 	 3:00 a.m. blood glucose at OD 340 (quarterly visit 05) 
blood glucose measurement 	phv00033197.v1 	 3:00 a.m. blood glucose at OD 340 (quarterly visit 24) 
blood glucose measurement 	phv00032635.v1 	 Post-breakfast blood glucose at OD 340 (quarterly visit 00) 
blood glucose measurement 	phv00032931.v1 	 Bedtime blood glucose at OD 340 (quarterly visit 12) 
blood glucose measurement 	phv00031331.v1 	 Experimental group: self blood glucose monitoring - less frequent daily schedule 
blood glucose measurement 	phv00027413.v1 	 Mean blood glucose value taken from BG profile: quarterly visit 20 
serum potassium	phv00007955.v3 	 BLOOD ANALYSIS: SERUM POTASSIUM 
blood calcium measurement	phv00078515.v3 	 High blood calcium 
serum LDL	phv00100043.v1 	 UNADJUSTED CALCULATED LDL (mg/dl) 
SERUM VLDL; TRIGLYCERIDES	phv00160505.v1 	 CALCULATED VLDL TRIGLYCERIDES (mg/dL) FROM NMR LIPOPROFILE-3 SPECTRAL ANALYSIS 
serum LDL	phv00163940.v1 	 Values: EOMI_Case (Early MI case); EOMI_Control (Early MI control); LDL_High; LDL_Low 
Leptin	phv00171665.v1 	 Year of the most recent study visit for which we have Leptin concentration 
SERUM CHOLESTEROL	phv00171683.v1 	 Year of the most recent study visit for which we have Total cholesterol 
Leptin	phv00171663.v1 	 Number of study visits for which we have Leptin concentration 
complete blood count	phv00077361.v3 	 CBC Visit type 
complete blood count	phv00077363.v3 	 CBC Days since randomization/enrollment 
Blood test	phv00026602.v1 	 Percentage of compliance with pre-supper (blood) tests 
CK-MB test	phv00170076.v1 	 CK-MB within norm % or index 
serum creatinine rate;albumin excretion rate	phv00034509.v1 	 SCR (serum creatinine rate) > 2, StdClr < 70, and AER (albumin excretion rate) > 300 simultaneously 
CBL10; urine test	phv00032571.v1 	 CBL10: Form date for 24-hr urine tests 
Blood test	phv00031219.v1 	 Diabetes monitoring - one or two daily injection(s): blood test(s) should have done before breakfast 
Blood test	phv00025665.v1 	 Diabetes monitoring (one or two daily injection[s]): blood test(s) done before lunch 
Blood test	phv00025995.v1 	 Diabetes monitoring (three or more daily injections or infusion pump): blood test(s) should have done before lunch 
Blood test	phv00025651.v1 	 Diabetes monitoring (three or more daily injections or infusion pump): blood test(s) done before lunch 
urine test	phv00026011.v1 	 Diabetes monitoring (one or two daily injection[s]): urine test(s) should have done before dinner 
laboratory test	phv00051127.v1 	 C5. Diagnostic tests performed. Result of test 1 
DFA	phv00015277.v1 	 F40.b. Oth DFA at Least 1 hour, (Participants with European ancestry). DIGS3 
ELISA; Lp-PLA2	phv00172226.v1 	 ELISA plate number for Lp-PLA2 Mass 
Estrogen Assay	phv00111135.v2 	 F130 Type of Estrogen Assay 
Estrogen Assay	phv00111160.v2 	 F130 Days to Estrogen Assay 
Factor VII measurement	phv00165200.v1 	 Age in years at Factor VII measurement 
blood glucose measurement 	phv00165196.v1 	 Blood fasting glucose at baseline in mg/dL 
Blood sugar	phv00066356.v1 	 Fasting Blood Sugar 
blood glucose measurement 	phv00163552.v1 	 Fasting glucose 
Hemoccult test	phv00078569.v3 	 Hemoccult test ever 
Fibronogen measurement	phv00163981.v1 	 Age in years at Fibrinogen measurement 
blood glucose measurement 	phv00065989.v1 	 B5f. Health insurance coverage. If you currently have health insurance, does it provide coverage for blood glucose testing meters 
Fructose; blood glucose measurement; galactose 	phv00172254.v1 	 Fructose + glucose + galactose 
 gamma glutamyl transferase measurement 	phv00172169.v1 	 Gamma glutamyltransferase (sample type: serum) 
genotyping	phv00066340.v1 	 Gender of participant has been confirmed with genotyping: 1 = Male, 2 = Female 
genotyping	phv00121977.v1 	 The chip a sample was genotyped on (Platform) 
genotyping	phv00054359.v1 	 SNP genotyping success rate: Y = at least 95% SNP genotyping success rate. (African American participants) 
genotyping	phv00073519.v1 	 Sample IDs of samples being genotyped 
genotyping	phv00073544.v2 	 Sample genotyping instance ID 
GFR; blood glucose measurement	phv00026497.v1 	 CBL00: GFR serum glucose - pre-injection (mg/dl) 
GFR; blood glucose measurement	phv00027347.v1 	 CBL2: GFR serum glucose - t3 value (mg/dl) 
GFR; blood glucose measurement	phv00030371.v1 	 CBL3: GFR serum glucose - t2 value (mg/dl) 
GFR; blood glucose measurement	phv00030986.v1 	 CBL9: GFR serum glucose - t1 value (mg/dl) 
GFR	phv00026660.v1 	 CBL6: GFR gamma count serum - t4 
GFR	phv00031575.v1 	 CBL4: GFR gamma count serum - t4 
GFR	phv00028515.v1 	 CBL7: GFR serum glucose - t4 value (mg/dl) 
GFR	phv00048507.v1 	 GFR (glomerular filtration rate) urine-volume: t-1 
blood glucose measurement 	phv00171640.v1 	 2-hour glucose concentration at the first study visit 
blood glucose measurement 	phv00049991.v1 	 J6a1. Potential contributing factors,  glucose monitoring: self blood glucose 
blood glucose measurement 	phv00118398.v2 	 3ML GRAY TUBE, 1ML SERUM(2 HR GLUCOSE). Q 28 
Urine glucose	phv00029075.v1 	 Standard treatment: performs urine glucose monitoring 
blood glucose measurement 	phv00001391.v1 	 GLUCOSE CHALLENGE: TIME OF LAST EATING, AM OR PM 
blood glucose measurement 	phv00126016.v1 	 Glucose fasting status 
blood glucose measurement 	phv00126331.v1 	 LFFQ: glucose (gm) 
blood glucose measurement 	phv00126182.v1 	 Glucose (g) 
blood glucose measurement 	phv00112339.v1 	 Baby's cord glucose 
blood glucose measurement 	phv00100051.v1 	 2 HR GLUCOSE (mg/dl) 
blood glucose measurement 	phv00094122.v1 	 GLUCOSE (VALUE IN MG/DL)          Q4A 
blood glucose measurement 	phv00032798.v1 	 Bedtime blood glucose mg/dl (quarterly visit 06) 
blood glucose measurement 	phv00032836.v1 	 Post-lunch blood glucose mg/dl (quarterly visit 08) 
blood glucose measurement 	phv00033162.v1 	 Post-breakfast blood glucose mg/dl (quarterly visit 23) 
blood glucose measurement 	phv00032886.v1 	 Bedtime blood glucose mg/dl (quarterly visit 10) 
blood glucose measurement 	phv00032774.v1 	 Post-supper blood glucose mg/dl (quarterly visit 05) 
blood glucose measurement 	phv00032926.v1 	 Pre-supper blood glucose mg/dl (quarterly visit 12) 
blood glucose measurement 	phv00033232.v1 	 Post-lunch blood glucose mg/dl (quarterly visit 26) 
blood glucose measurement 	phv00032990.v1 	 Post-lunch blood glucose mg/dl (quarterly visit 15) 
blood glucose measurement 	phv00033408.v1 	 Post-lunch blood glucose mg/dl (quarterly visit 34) 
blood glucose measurement 	phv00033362.v1 	 Pre-lunch blood glucose mg/dl (quarterly visit 32) 
blood glucose measurement 	phv00033498.v1 	 Pre-supper blood glucose mg/dl (quarterly visit 38) 
blood glucose measurement 	phv00033032.v1 	 Pre-lunch blood glucose mg/dl (quarterly visit 17) 
blood glucose measurement 	phv00032632.v1 	 Pre-breakfast blood glucose mg/dl (quarterly visit 00) 
blood glucose measurement 	phv00032794.v1 	 Pre-supper blood glucose mg/dl (quarterly visit 06) 
blood glucose measurement 	phv00033082.v1 	 Post-supper blood glucose mg/dl (quarterly visit 19) 
blood glucose measurement 	phv00033414.v1 	 Bedtime blood glucose mg/dl (quarterly visit 34) 
blood glucose measurement 	phv00030736.v1 	 T31-blood glucose profile (bgp) 7 - mg/dl 
blood glucose measurement 	phv00033264.v1 	 Blood glucose profile 8 - mg/dl (quarterly visit 27) 
glutamin acid	phv00126817.v1 	 LFFQ: glutamic acid (gm) 
blood test	phv00050651.v1 	 B8c3. Health care delivery. Other blood tests: paid other insurance 
Hematocrit	phv00094454.v1 	 HEMATOCRIT                           Q5 
Hematocrit	phv00106920.v1 	 HEMATOCRIT (%) 
Hematocrit	phv00165217.v1 	 Hematocrit at designated visit (may not be baseline) in % 
 HOMOCYSTEINE 	phv00021934.v3 	 HOMOCYSTEINE 
 HOMOCYSTEINE 	phv00024660.v3 	 HOMOCYSTEINE (UMOL/L) 
 HOMOCYSTEINE 	phv00121021.v2 	 Y0 HOMOCYSTEINE (umol/L) - 2003 RUN 
laboratory test	phv00066107.v1 	 D4h. Hospitalization and other health care services used. During the past 12 months, have you had any of the following laboratory tests: dilated eye, in past 12 months 
laboratory test	phv00050919.v1 	 D4g1. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: stress test -number of times 
laboratory test; fasting lipid test	phv00050912.v1 	 D4d. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: fasting lipid test 
laboratory test; urine test	phv00050930.v1 	 D4m. Hospitalization and other health care services used. During the past 12months, have you had any of the following laboratory tests: other urine tests 
serum cholesterol 	phv00010094.v3 	 DID YOU EVER HAVE HIGH BLOOD CHOLESTEROL (> 240 MG/DL) 
Immunophenotyping; cytochemistry; CD15	phv00073694.v4 	 Immunophenotype & Cytochemistry: CD15 
Immunophenotyping; cytochemistry; CD3	phv00163819.v2 	 Immunophenotype & Cytochemistry: CD3 % Positive 
 Immunophenotyping; Cytochemistry; CD13 	phv00163823.v2 	 Immunophenotype & Cytochemistry: CD13 % Positive 
fluorescence in situ hybridization; 	phv00163886.v2 	 :TEL-AML1: For FISH tested indicate % 
fluorescence in situ hybridization	phv00163883.v2 	 :MLL: For FISH tested indicate % 
insulin; ELISA	phv00070362.v4 	 INSULIN, PMOL/L (ELISA RESULTS WERE MULTIPLIED BY A FACTOR OF 6 TO GET PMOL/L UNITS FOR INSULIN) 
INTERLEUKIN-6	phv00023796.v3 	 INTERLEUKIN-6 FROM SERUM (PG/ML) 
Laboratory culture	phv00159437.v2 	 1st, 2nd, 3rd, etc. culture taken for a particular subject. 
lipid test	phv00031767.v1 	 CBL5: Lipid test - 24: collection date 
lipid test	phv00031103.v1 	 CBL8: Lipid test - 24: collection date 
lipid test	phv00027395.v1 	 CBL2: Lipid test - 24: collection date 
lipid test	phv00028562.v1 	 CBL7: Lipid test - 24: collection date 
lipid test	phv00030416.v1 	 CBL3: Lipid test - 21: collection date 
renal test	phv00031757.v1 	 CBL5: Renal test - 19: raw clearance value (ml/mn) 
renal test	phv00027384.v1 	 CBL2: Renal test - 18: patient's weight in kg 
LDH1;LDH2	phv00121281.v2 	 LDH1 & LDH2 AVAILABLE 
Lymphocyte count	phv00128717.v1 	 REASON FOR MISSING DATA: ESTIMATED %CD8, AS A PERCENT OF LYMPHOCYTES 
Lymphocyte count	phv00128704.v1 	 LYMPHOCYTE COUNT  x10^3/ul 
Lymphocyte count	phv00128734.v1 	 PERCENT LYMPHOCYTES IN WHOLE BLOOD THAT ARE CD4+ 
renal test; urine creatinine 	phv00027382.v1 	 CBL2: Renal test - 16: creatinine (urine) value  (mg/dl) 
renal test; urine creatinine 	phv00031596.v1 	 CBL4: Renal test - 16: creatinine (urine) value  (mg/dl) 
URINARY MAGNESIUM	phv00116107.v2 	 URINARY MAGNESIUM (UNADJUSTED):DAY 1 
urea nitrogen	phv00031078.v1 	 CBL8: 24-hr urine: urea nitrogen (mg/dl) 
urine creatinine	phv00031007.v1 	 CBL9: 24-hr urine: creatinine/urine: value (mg/dl) 
urine creatinine	phv00030392.v1 	 CBL3: 24-hr urine: creatinine/specimen value (mg/spec) 
Mean corpuscular hemoglobin concentration	phv00124417.v1 	 Mean corpuscular hemoglobin concentration in grams per deciliter 
MEAN CORPUSCULAR VOLUME	phv00094435.v1 	 MEAN CORPUSCULAR VOLUME (MCV)     Q13 
MEAN CORPUSCULAR VOLUME	phv00164625.v1 	 Mean corpuscular volume in femtoliters at designated visit (may not be baseline) 
lipid test; LDL	phv00027329.v1 	 CBL1: Lipid test - 24: LDL cholesterol (serum) value  (mg/dl) 
lipid test; triglyceride	phv00027393.v1 	 CBL2: Lipid test - 22: triglyceride (serum) value  (mg/dl) 
laboratory test	phv00050429.v1 	 B8e1. Health care delivery. During the past 6 months have you had laboratory test: stress test, how many times 
urine test	phv00050676.v1 	 B8h3. Health care delivery. Urine tests: paid by other insurance 
HDL; serum cholesterol	phv00024694.v3 	 HDL PARTICLES 9.4+/-0.6 NM (EXPRESSED AS CHOLESTEROL CONCENTRATIONS IN MG/DL) AND DETERMINED USING NMR, EXAM 4 
niacin	phv00126892.v1 	 RECALL: niacin 
glutamic acid	phv00126946.v1 	 RECALL: glutamic acid 
pantothenic acid	phv00126484.v1 	 RECALL: pantothenic acid 
total protein	phv00126449.v1 	 RECALL: total protein 
insulin; metabolic clearance rate	phv00123982.v1 	 ISI (0,120) = Metabolic clearance rate / log (Mean Serum Insulin) 
C-reative protein	phv00085016.v2 	 NATURAL LOG TRANSFORMED C-REACTIVE PROTEIN (CRP) 
monocyte count	phv00128745.v1 	 REASON FOR MISSING DATA: PERCENT OF MONOCYTES THAT ARE TF+ IN UNSTIMULATED EXPRESSION ASSAY 
monocyte count	phv00165226.v1 	 Monocytes in absolute numbers at designated visit (may not be baseline). 
myelocyte count	phv00163844.v2 	 Differential Count (Peripheral Blood): Myelocytes 
RNA; NPPA; Run2; platelet	phv00142129.v2 	 RNA LEVELS: NPPA, Run2, Platelet (TaqmanAssayID : Hs00383231_m1) 
niacin	phv00126354.v1 	 LFFQ: niacin (mg) 
niacin	phv00126616.v1 	 SFFQ: niacin (mg) 
niacin; nicotinic acid	phv00086534.v2 	 NIACIN AND NICOTINIC ACID 
HDL; serum cholesterol	phv00085923.v2 	 HDL CHOLESTEROL, NCEP CATEGORIES 
INTERLEUKIN-6	phv00080994.v3 	 Interleukin-6 raw OD reading for second well 
osteoprotegerin	phv00156660.v2 	 Osteoprotegerin raw OD reading for second well 
pregnancy test	phv00049318.v1 	 O2e. Female/ reproductive: did test indicate pregnancy 
uric acid	phv00127638.v1 	 Uric acid character result 
sequencing	phv00161369.v3 	 PHENOTYPE SAMPLE WAS SEQUENCED FOR 
granule membrane protein 140; p-selectin	phv00173446.v1 	 Granule membrane protein 140 (P-selectin) (sample type: plasma) 
RNA; CACNB2; Run3; platelet	phv00142180.v2 	 RNA LEVELS: CACNB2, Run3, Platelet (TaqmanAssayID : Hs00167861_m1) 
RNA; B2M; Run3; platelet	phv00142178.v2 	 RNA LEVELS: B2M, Run3, Platelet (TaqmanAssayID : Hs99999907_m1) 
RNA; FLJ36031; Run4; platelet	phv00142341.v2 	 RNA LEVELS: FLJ36031, Run4, Platelet (TaqmanAssayID : Hs00703139_s1) 
